Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Peoria, IL, Jan 8, 2025 — Veloxity Labs, a bioanalytical contract research organization (CRO) specializing in accelerating ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

Alongside plans to spin out a new company, the Belgian drugmaker said it will cut some 300 positions, or about 40% of its ...

January 7th, 2025 – Bioforum, The Data Masters, a leading global clinical research organization (CRO) specializing in ...

Zetagen has enlisted Foley & Lardner LLP as its intellectual property counsel and maintains a collaborative professional relationship with Steve Maebius, Esq. Foley & Lardner LLP is a prominent law ...

In 2024, the company forged new partnerships with three of the largest, global pharmaceutical companies in the world, realizing a total of 10 partnerships with leading life science companies. Viz.ai ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...

The startup is developing macrocyles, which share strengths of both small molecules and biologics, as oral medicines against ...